Related Experiment Video
Updated: Feb 9, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Increased Cardiovascular Risk in Hypertriglyceridemic Patients With Statin-Controlled LDL Cholesterol
Gregory A Nichols1, Sephy Philip2, Kristi Reynolds3
1Kaiser Permanente Center for Health Research, Portland, Oregon.
Insights
High triglyceride levels increase cardiovascular disease risk in statin-treated patients with controlled LDL-C. This study highlights the importance of managing triglyceride levels for high-risk individuals.
Area of Science:
- Cardiology
- Epidemiology
- Pharmacology
Background:
- Real-world data on high triglyceride (TG) and cardiovascular disease (CVD) risk in statin-treated patients with controlled low-density lipoprotein cholesterol (LDL-C) is limited.
- Understanding this relationship is crucial for optimizing CVD prevention strategies.
Purpose of the Study:
- To compare the risk of CVD and mortality between patients with high TG levels and those with normal TG levels.
- To provide real-world evidence on the impact of TG levels on cardiovascular outcomes in a specific patient population.
Main Methods:
- A longitudinal observational cohort study was conducted within an integrated delivery system.
- Patients aged ≥45 years with diagnosed CVD, on statin therapy, and with LDL-C between 40-100 mg/dL were included.
- TG levels were categorized as normal (<150 mg/dL) or high (200-499 mg/dL) in 2010, with follow-up through 2016.
Main Results:
- The study included 14,481 patients with normal TG and 2702 with high TG.
- High TG levels were associated with a 10% greater adjusted incidence of a composite outcome including nonfatal myocardial infarction (MI), stroke, unstable angina, and revascularization (RR 1.10, P=0.041).
- Specific drivers included nonfatal MI (RR 1.20), coronary revascularization (RR 1.18), and peripheral revascularization (RR 1.56).
Conclusions:
- High triglyceride levels are associated with increased cardiovascular disease risk in high-risk, statin-treated patients with atherosclerotic CVD.
- These findings underscore the importance of TG management in addition to LDL-C control for preventing CVD events.
Context:
Real-world evidence of the relationship between high triglyceride (TG) levels and cardiovascular (CV) disease (CVD) risk among statin-treated patients with low-density lipoprotein cholesterol (LDL-C) control is lacking.
Objective:
We aimed to compare CVD and mortality risk between patients with high vs normal TGs.
Design:
Longitudinal observational cohort study.
Setting:
Integrated delivery system.
Patients:
Patients aged ≥45 years whose TG level was either <150 mg/dL (normal) or between 200 and 499 mg/dL (high) in 2010, were taking only statins, had LDL-C values 40 to 100 mg/dL, and had diagnosed CVD.
Outcome Measures:
Patients were followed through December 2016. Our primary outcomes were a composite of nonfatal myocardial infarction (MI), nonfatal stroke, unstable angina, coronary revascularization, and all-cause mortality and a second composite adding peripheral revascularization and aneurysm repair. We compared multivariable-adjusted incidence rates and rate ratios (RRs) of the outcomes and their components.
Results:
A total of 14,481 patients comprised the normal TG group, and 2702 patients were in the high TG group. Multivariable-adjusted incidence of the second composite was 10% greater in the high TG group [50.9/1000 person-years, 95% CI 47.0 to 55.2 vs 46.5, 44.8 to 48.2, RR 1.10, 95% CI 1.00 to 1.20, P = 0.041]. The difference was driven by nonfatal MI (RR 1.20, 95% CI 1.00 to 1.45, P = 0.045), coronary revascularization (RR 1.18, 95% CI 1.00 to 1.40, P = 0.045), and peripheral revascularization (RR 1.56, 95% CI 1.14 to 2.13, P = 0.006).
Conclusions:
CVD risk in high-risk statin-treated patients with atherosclerotic CVD was associated with high TG levels.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Increasing Function
Relative Risk
Overview of the Cardiovascular System
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
Increased Body Temperature

